Pfizer (PFE) Tops Q1 EPS by 15c, Raises FY Guidance

May 4, 2021 6:47 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Pfizer (NYSE: PFE) reported Q1 EPS of $0.93, $0.15 better than the analyst estimate of $0.78. Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $13.6 billion.


Pfizer sees FY2021 EPS of $3.55-$3.65, versus the consensus of $3.36. Pfizer sees FY2021 revenue of $70.5-72.5 billion, versus the consensus of $62.99 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities